论文信息 - 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin’s lymphoma - 字舞流文

90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin’s lymphoma

T. Waldmann | E. Jaffe | S. Pittaluga | M. Brechbiel | J. Carrasquillo | M. Whatley | C. Redon | W. Bonner | J. Janik | C. Goldman | Clara C. Chen | D. O'mahony | R. Junghans | C. Paik | T. Fleisher | K. Conlon | D. Stewart | Jeffrey D. White | Jae-Ho Lee | B. Bryant | T. Worthy | J. Morris | S. Fioravanti | Erin M. Corcoran | Cathryn C. Lee | Margaret Brown